Clinical Trials Directory

Trials / Completed

CompletedNCT01199276

Hip Fracture Surgery in Elderly Patients

An International, Multi-center, Randomized, Controlled Trial Evaluating The Effect of Xenon on Post-operative Delirium in Elderly Patients Undergoing Hip Fracture Surgery

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
256 (actual)
Sponsor
Air Liquide Santé International · Industry
Sex
All
Age
75 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the incidence of Post-Operative Delirium (POD), diagnosed with the Confusion Assessment Method (CAM), in elderly patients undergoing hip fracture surgery under general anaesthesia with xenon or sevoflurane, for a period of four days post-surgery.

Conditions

Interventions

TypeNameDescription
DRUGXenonGroup A: xenon 60% (55%-65%)(1 MAC) in oxygen (FiO2 = 0.35-0.45)
DRUGSevofluraneGroup B: sevoflurane 1.1-1.4%(1 MAC) in oxygen (FiO2 = 0.35-0.45) and Medical air

Timeline

Start date
2010-09-01
Primary completion
2014-10-01
Completion
2014-10-01
First posted
2010-09-10
Last updated
2015-07-27

Locations

13 sites across 6 countries: Belgium, France, Germany, Italy, Spain, United Kingdom

Source: ClinicalTrials.gov record NCT01199276. Inclusion in this directory is not an endorsement.

Hip Fracture Surgery in Elderly Patients (NCT01199276) · Clinical Trials Directory